Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints.
about
Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosisA randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patientsUpdate on antifungal therapy.Voriconazole: a new triazole antifungal.Towards a common susceptibility testing method?Novel triazole antifungal agents.Comparison of multilocus sequence typing and pulsed-field gel electrophoresis as tools for typing Staphylococcus aureus isolates in a microepidemiological setting.Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections.Voriconazole: therapeutic review of a new azole antifungal.Voriconazole: review of a broad spectrum triazole antifungal agent.Developments in the treatment of candidiasis: more choices and new challenges.Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing.Antimicrobial susceptibility of long term care facility and general practice urine samples in patients 65 years and older: an observational study.The ica operon and biofilm production in coagulase-negative Staphylococci associated with carriage and disease in a neonatal intensive care unit.Towards better antimicrobial susceptibility testing: impact of the Journal of Antimicrobial Chemotherapy.Reemergence of Chloramphenicol Sensitivity in Enteric Fever.Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates.Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species.Genetic population structure of coagulase-negative staphylococci associated with carriage and disease in preterm infants.
P2860
Q27342229-F241238D-80E4-4A29-924E-FFCE7F75F932Q28189320-99416EBC-2AEE-4489-A7DC-424337019585Q33648695-1C35E54B-A2D6-4F48-9C39-DA204462A2EAQ33917339-580F8440-5A03-4C69-AEB1-45222AD49C82Q33933079-AFE024A3-F7D0-4525-9683-2061A313D622Q34074772-C1A8A5FE-36EA-438F-816E-DE149992E9F1Q34201236-E47358D8-D6B6-41A6-A94D-C4A5B2B629D8Q35784526-5A08C1EE-B850-4085-BBCA-8B778666F0AEQ35917452-292875B5-47C7-4A69-8DB3-3D51BCAA67EFQ36164008-AE80AE5F-5F24-4929-8C3A-214F3ACF3A01Q36623050-D02C16C4-2B32-4AD9-AB42-B76BB4C19226Q37713450-B7D7DF89-22C2-44DE-A09B-838FE0C3F13BQ38806162-19B2826D-C51E-4933-9D4A-17578B96E48EQ39746593-4352ECE4-7214-4287-B4D2-1F357C4B74E2Q40361053-34F2C2D0-5D48-4BE5-A16A-8CA71BD747B1Q40445816-8E43224B-B9EF-4C1D-9BA3-1C01FF2AF22FQ47199583-E1D29F98-D108-48B9-9E8C-687936CC04F7Q50515241-2D928398-DDBD-463F-BCC9-26B34C917906Q53993085-4AAD9D99-6B48-455E-96B7-4B3BE27E8D70
P2860
Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Comparison of the modified Sto ...... bial Chemotherapy breakpoints.
@en
Comparison of the modified Sto ...... bial Chemotherapy breakpoints.
@nl
type
label
Comparison of the modified Sto ...... bial Chemotherapy breakpoints.
@en
Comparison of the modified Sto ...... bial Chemotherapy breakpoints.
@nl
prefLabel
Comparison of the modified Sto ...... bial Chemotherapy breakpoints.
@en
Comparison of the modified Sto ...... bial Chemotherapy breakpoints.
@nl
P2093
P356
P1476
Comparison of the modified Sto ...... bial Chemotherapy breakpoints.
@en
P2093
Andrews JM
MacGowan AP
Sunderland J
P304
P356
10.1093/JAC/42.2.161
P407
P577
1998-08-01T00:00:00Z